These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24968885)

  • 1. Prediction of stroke in patients without atrial fibrillation using the CHADS2 and CHA2DS2-VASc scores: a justification for more widespread thromboprophylaxis?
    Senoo K; Lip GY
    Heart; 2014 Oct; 100(19):1485-6. PubMed ID: 24968885
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
    Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
    Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Lane DA; Buller H; Lip GY
    Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of stroke and the need for thromboprophylaxis in young patients with atrial fibrillation: a cohort study.
    Lin AH; Oakley LS; Phan HL; Shutt BJ; Birgersdotter-Green U; Francisco GM
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):189-93. PubMed ID: 24625564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation and stroke].
    Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D
    Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
    Chua SK; Shyu KG; Lu MJ; Lien LM; Lin CH; Chao HH; Lo HM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):919-926.e1. PubMed ID: 23628495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between CHADS2 score and CHA2DS2-VASc score on assessing the risk of ischemic stroke in patients with nonvalvular atrial fibrillation].
    Xiang W; Wang Y; Liu F; Liu M; Feng X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):389-91. PubMed ID: 25042916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Wegner C; Finsterer J
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):709-12. PubMed ID: 22142779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
    Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
    Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.